LU90907I2 - Foscan et ses dérivés pharmaceutiquement acceptables (temoporfin) - Google Patents

Foscan et ses dérivés pharmaceutiquement acceptables (temoporfin)

Info

Publication number: LU90907I2
Authority: LU; Luxembourg
Prior art keywords: foscan; temoporfin; pharmaceutically acceptable; acceptable derivatives; same
Prior art date: 1988-03-11

Application number

LU90907C

Other languages

English (en)

Original Assignee

Bioscience Technology Invest H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-03-11

Filing date

2002-04-10

Publication date

2003-04-30

2002-04-10 Application filed by Bioscience Technology Invest H filed Critical Bioscience Technology Invest H

2003-04-30 Publication of LU90907I2 publication Critical patent/LU90907I2/fr

Links

LYPFDBRUNKHDGX-SOGSVHMOSA-N N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 Chemical compound N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 LYPFDBRUNKHDGX-SOGSVHMOSA-N 0.000 title 2
229960002197 temoporfin Drugs 0.000 title 2
150000001875 compounds Chemical class 0.000 abstract 4
125000001424 substituent group Chemical group 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
150000004036 bacteriochlorins Chemical class 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
238000005286 illumination Methods 0.000 abstract 1
230000017074 necrotic cell death Effects 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
150000004032 porphyrins Chemical class 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

LU90907C 1988-03-11 2002-04-10 Foscan et ses dérivés pharmaceutiquement acceptables (temoporfin) LU90907I2 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB888805849A GB8805849D0 (en)	1988-03-11	1988-03-11	Porphyrins & cancer treatment

Publications (1)

Publication Number	Publication Date
LU90907I2 true LU90907I2 (fr)	2003-04-30

Family

ID=10633278

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU90907C LU90907I2 (fr)	1988-03-11	2002-04-10	Foscan et ses dérivés pharmaceutiquement acceptables (temoporfin)

Country Status (17)

Country	Link
US (1)	US4992257A (fr)
EP (1)	EP0337601B1 (fr)
JP (1)	JP2785033B2 (fr)
KR (1)	KR970011392B1 (fr)
AT (1)	ATE89002T1 (fr)
AU (1)	AU611774C (fr)
BR (1)	BR1100662A (fr)
CA (1)	CA1338737C (fr)
DE (2)	DE10299012I2 (fr)
ES (1)	ES2055038T3 (fr)
GB (1)	GB8805849D0 (fr)
HK (1)	HK129693A (fr)
IE (1)	IE63290B1 (fr)
LU (1)	LU90907I2 (fr)
NL (1)	NL300089I2 (fr)
NZ (1)	NZ228225A (fr)
ZA (1)	ZA891653B (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5162519A (en) *	1988-03-11	1992-11-10	Efamol Holdings Plc	Porphyrins and cancer treatment
US5219878A (en) *	1990-10-05	1993-06-15	Queen's University	Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
US5262532A (en) *	1991-07-22	1993-11-16	E.R. Squibb & Sons, Inc.	Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging
US6362175B1 (en) *	1991-09-20	2002-03-26	The Trustees Of The University Of Pennsylvania	Porphyrin compounds for imaging tissue oxygen
PL165249B1 (pl) *	1991-10-29	1994-11-30	Wojskowa Akad Tech	Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
WO1994012239A1 (fr) *	1992-11-20	1994-06-09	University Of British Columbia	Procede d'activitation d'agents photosensibles
US6127356A (en)	1993-10-15	2000-10-03	Duke University	Oxidant scavengers
JPH07233065A (ja)	1993-12-27	1995-09-05	Canon Inc	ピリリウム塩又はピリリウム類似塩を含む光化学治療薬
GB9408746D0 (en) *	1994-05-03	1994-06-22	Scotia Holdings Plc	Tumour locallising photosensitising compounds
WO1996009053A1 (fr) *	1994-09-20	1996-03-28	Duke University	Activite d'oxydoreductase de porphyrines manganiques
US6210356B1 (en) *	1998-08-05	2001-04-03	Ekos Corporation	Ultrasound assembly for use with a catheter
US6176842B1 (en)	1995-03-08	2001-01-23	Ekos Corporation	Ultrasound assembly for use with light activated drugs
AU725602B2 (en) *	1995-06-07	2000-10-12	Duke University	Oxidant scavengers
US5877165A (en) *	1995-11-02	1999-03-02	Brookhaven Science Associates	Boronated porhyrins and methods for their use
DE69718268D1 (de)	1996-10-03	2003-02-13	Canon Kk	Verfahren zur Detektion von Zielnukleinsäure, Verfahren zu ihrer Quantifizierung und Pyrylium-Verbindungen zur Chemilumineszenz-Analyse
US6676626B1 (en)	1998-05-01	2004-01-13	Ekos Corporation	Ultrasound assembly with increased efficacy
US6582392B1 (en) *	1998-05-01	2003-06-24	Ekos Corporation	Ultrasound assembly for use with a catheter
WO1999023097A1 (fr)	1997-11-03	1999-05-14	Duke University	Porphyrines substituees
DE19814405C2 (de) *	1998-03-31	2000-03-02	Schastak Astrid	Porphyrine und ihre Verwendung als Photosensitizer
ES2257858T3 (es)	1998-04-24	2006-08-01	Duke University	Porfirinas sustituidas.
EP1107971B1 (fr) *	1998-08-28	2004-11-24	Destiny Pharma Limited	Derives porphyrine, leur utilisation en therapie photodynamique, et dispositifs medicaux les contenant
ATE312103T1 (de)	1999-01-25	2005-12-15	Nat Jewish Med & Res Center	Substituierte porphyrine und deren therapeutische verwendungen
US6482943B1 (en) *	1999-04-30	2002-11-19	Slil Biomedical Corporation	Quinones as disease therapies
GB0001455D0 (en) *	2000-01-21	2000-03-15	Scotia Holdings Plc	Porphyrins and related compounds
DE60233317D1 (de)	2001-01-19	2009-09-24	Nat Jewish Med & Res Center	Medikament zum schutz in der radiotherapie
EP1439842A4 (fr)	2001-06-01	2009-09-02	Nat Jewish Med & Res Center	Capteurs oxydants destines au traitement du diabete ou a etre utilises dans une transplantation ou a induire une tolerance immunitaire
US7220239B2 (en)	2001-12-03	2007-05-22	Ekos Corporation	Catheter with multiple ultrasound radiating members
PT102721B (pt) *	2002-02-01	2011-01-24	Cipan Companhia Industr Prod De Antibioticos S A	Compostos macrocíclicos tetrapirrólicos com rendimento quântico de oxigénio singuleto adequado à terapia fotodinâmica e processos para a sua preparação
US8226629B1 (en)	2002-04-01	2012-07-24	Ekos Corporation	Ultrasonic catheter power control
US7485721B2 (en)	2002-06-07	2009-02-03	Duke University	Substituted porphyrins
US6921371B2 (en) *	2002-10-14	2005-07-26	Ekos Corporation	Ultrasound radiating members for catheter
ITFI20020200A1 (it) *	2002-10-21	2004-04-22	Molteni & C Dei Flii Alitti S P A Societa L	Porfirine meso-sostituite.
CA2437638A1 (fr)	2003-08-20	2005-02-20	John Robert North	Therapie photodynamique
US20050048109A1 (en) *	2003-08-26	2005-03-03	Ceramoptec Industries, Inc.	Non-polar photosensitizer formulations for photodynamic therapy
CA2457214A1 (fr)	2004-02-06	2005-08-06	Qlt Inc.	Therapie photodynamique pour le traitement de l'acne
JP2008501727A (ja)	2004-06-09	2008-01-24	キューエルティーインク．	外用塗布した疎水性緑色ポルフィリンを用いた機能亢進性皮脂腺障害を治療するための光線力学的療法
US7825153B2 (en) *	2004-08-16	2010-11-02	Ceramoptec Industries, Inc.	Photosensitizer formulations and their use
DE102005015286A1 (de) *	2005-04-04	2006-10-05	Tetrapdt Gmbh	Photosensibilisatoren als Arzneimittelträger für lokale Markierung und Therapie von neoplastischem Gewebe
US10182833B2 (en)	2007-01-08	2019-01-22	Ekos Corporation	Power parameters for ultrasonic catheter
ES2471118T3 (es)	2007-06-22	2014-06-25	Ekos Corporation	Método y aparato para el tratamiento de hemorragias intracraneales
US20090036952A1 (en)	2007-07-30	2009-02-05	National Yang-Ming University	Induction driven light module and use thereof
WO2009079415A1 (fr) *	2007-12-14	2009-06-25	Ekos Corporation	Détermination d'impulsions ultrasonores
CN102105146A (zh)	2008-05-23	2011-06-22	国立犹太保健医院	用于治疗与暴露于烷化物质有关的损伤的方法
ES2707228T3 (es)	2008-09-18	2019-04-03	Biolitec Unternehmensbeteiligungs Ii Ag	Nuevo método y aplicación de porfirinas y clorinas asimétricamente meso-sustituidas para TFD
US9211283B2 (en)	2009-12-11	2015-12-15	Biolitec Pharma Marketing Ltd	Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
BR112013017953A2 (pt)	2011-01-13	2017-08-29	Quadra Logic Tech Inc	Composição farmacêutica, formulação tópica, método, e, composição fotossensibilizadora
CN104703624A (zh)	2012-07-11	2015-06-10	德米拉股份有限公司	局部递送光敏剂的药物组合物及其应用
US9550072B2 (en)	2012-08-03	2017-01-24	Cerca Solutions, LLC	Diagnostic device, therapeutic device, and uses thereof
US10456375B2 (en)	2014-09-30	2019-10-29	Biolitec Unternehmensbeteiligungs Ii Ag	Specifically meso-substituted porphyrins and chlorins for photodynamic therapy
EP3307388B1 (fr)	2015-06-10	2022-06-22	Ekos Corporation	Cathéter à ultrasons
EP3894421A1 (fr)	2018-12-10	2021-10-20	Universität Hamburg	Porphyrines et chlorines glyco-substituées de façon spécifique pour une thérapie photodynamique
WO2022074014A1 (fr)	2020-10-05	2022-04-14	Biolitec Unternehmensbeteiligungs Ii Ag	Composés à base de tétrapyrrole et leurs formulations pour une thérapie antimicrobienne

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2740794A (en) *	1954-07-26	1956-04-03	Exxon Research Engineering Co	Synthesis of novel vanadium porphyrin
US3076813A (en) *	1957-11-13	1963-02-05	Monsanto Chemicals	alpha, beta, gamma, sigma-tetra-arylporphins
US3687863A (en) *	1970-05-25	1972-08-29	Gen Telephone & Elect	Optical filters containing tetraphenyl-porphins and method of making same
DE2308252A1 (de) *	1973-02-20	1974-08-22	Basf Ag	Verfahren zur herstellung von mesotetraarylporphinen
US4330637A (en) *	1981-01-05	1982-05-18	Western Electric Company, Inc.	Encapsulated electronic devices and encapsulating compositions
DE3464252D1 (en) *	1983-06-03	1987-07-23	Hoffmann La Roche	Labelled molecules for fluorescence immunoassays and processes and intermediates for their preparation
GB8429845D0 (en) *	1984-11-26	1985-01-03	Efamol Ltd	Porphyrins & cancer treatment
GB8522670D0 (en) *	1985-09-13	1985-10-16	Efamol Ltd	Drug treatments

1988
- 1988-03-11 GB GB888805849A patent/GB8805849D0/en active Pending
1989
- 1989-02-27 AT AT89301924T patent/ATE89002T1/de active
- 1989-02-27 ES ES89301924T patent/ES2055038T3/es not_active Expired - Lifetime
- 1989-02-27 EP EP89301924A patent/EP0337601B1/fr not_active Expired - Lifetime
- 1989-02-27 DE DE2002199012 patent/DE10299012I2/de active Active
- 1989-02-27 DE DE89301924T patent/DE68906301T2/de not_active Expired - Lifetime
- 1989-03-02 US US07/317,984 patent/US4992257A/en not_active Expired - Lifetime
- 1989-03-02 IE IE68789A patent/IE63290B1/en not_active IP Right Cessation
- 1989-03-03 ZA ZA891653A patent/ZA891653B/xx unknown
- 1989-03-03 AU AU30975/89A patent/AU611774C/en not_active Expired
- 1989-03-03 CA CA000592741A patent/CA1338737C/fr not_active Expired - Lifetime
- 1989-03-06 NZ NZ228225A patent/NZ228225A/xx unknown
- 1989-03-09 JP JP1055272A patent/JP2785033B2/ja not_active Expired - Lifetime
- 1989-03-10 KR KR1019890002955A patent/KR970011392B1/ko not_active Expired - Fee Related
1993
- 1993-11-25 HK HK1296/93A patent/HK129693A/en not_active IP Right Cessation
1997
- 1997-05-07 BR BR1100662-5A patent/BR1100662A/pt active IP Right Grant
2002
- 2002-04-10 LU LU90907C patent/LU90907I2/fr unknown
- 2002-04-15 NL NL300089C patent/NL300089I2/nl unknown

Also Published As

Publication number	Publication date
KR890014548A (ko)	1989-10-24
IE63290B1 (en)	1995-04-05
DE68906301D1 (de)	1993-06-09
US4992257A (en)	1991-02-12
ATE89002T1 (de)	1993-05-15
AU3097589A (en)	1989-09-14
DE68906301T2 (de)	1993-09-30
NZ228225A (en)	1990-08-28
ES2055038T3 (es)	1994-08-16
IE890687L (en)	1989-09-11
BR1100662A (pt)	1999-10-13
DE10299012I1 (de)	2002-07-18
NL300089I2 (nl)	2002-08-01
JP2785033B2 (ja)	1998-08-13
DE10299012I2 (de)	2004-05-06
EP0337601A1 (fr)	1989-10-18
ZA891653B (en)	1989-11-29
EP0337601B1 (fr)	1993-05-05
JPH01275528A (ja)	1989-11-06
AU611774B2 (en)	1991-06-20
HK129693A (en)	1993-12-03
GB8805849D0 (en)	1988-04-13
KR970011392B1 (ko)	1997-07-10
CA1338737C (fr)	1996-11-26
AU611774C (en)	2002-02-21
NL300089I1 (nl)	2002-07-01

Publication	Publication Date	Title
LU90907I2 (fr)	2003-04-30	Foscan et ses dérivés pharmaceutiquement acceptables (temoporfin)
AU578329B2 (en)	1988-10-20	Anti cancer treatment with porphyrins
DE3576823D1 (de)	1990-05-03	Infrarot-absorber.
PT1063234E (pt)	2003-09-30	Derivados de taxano hidrofobos
NL300241I1 (nl)	2006-12-01	Hydroxymethyl(methyleencyclopentyl)uurines en -pyrimidines.
NO930774D0 (no)	1993-03-03	Baccatin-iii-derivater
DE69131581D1 (de)	1999-10-07	2-Oxindolderivate als Tyrosinekinaseinhibitoren
DE69325944D1 (de)	1999-09-16	s-Triazinderivate als Lichtschutzmittel
ATE119774T1 (de)	1995-04-15	Imidazopyridinderivate und ihre verwendung.
CA2284879A1 (fr)	1998-11-12	Esters d'ethyleneglycol de derives de monohydrobenzopophyrine utilises comme agents photosensibles
FI943142A0 (fi)	1994-06-30	Amidi- ja ureajohdannaiset, joilla on veren korkeita kolesteroliarvoja vastustava vaikutus, niiden valmistus ja terapeuttiset käytöt
CA2015473A1 (fr)	1990-10-28	Derives de triphenylmethane
ATE101601T1 (de)	1994-03-15	Fluorhaltige nitrazol-derivate und diese umfassender strahlungssensibilisator.
AU2359392A (en)	1993-03-25	Dihydropyridine derivatives useful in antitumor therapy
ATE170861T1 (de)	1998-09-15	Antibiotische carbapenemderivate
GR852762B (fr)	1986-03-13